Articles
Latest Articles
Commentaries
Deals
Distillery
Emerging Companies
Finance
Politics, Policy & Law
Product Development
Regulation
Targets & Mechanisms
Tools & Techniques
Current Editions
Search Archives
BCIQ
Company Profiles
Target Profiles
Product Profiles
Conferences
China Healthcare Summit
Bio€quity Europe
White Papers
Free Trial
/
Subscribe
Sign In
more_vert
Biocentury
Company Profiles
Target Profiles
Product Profiles
Free Trial Information
Export Pdf
Overview
Pipeline
Deals
Financings
Earnings Summary
Stock Summary
Articles
BioCentury
|
Jul 25, 2016
Strategy
Paving the way
...Korea Intas Pharmaceuticals Ltd. Mkt in India Novartis AG (NYSE:NVS; SIX:NOVN) Registration in U.S., EU
Mycenax Biotech Inc.
...
Read More
BioCentury
|
Jan 6, 2014
Finance
2014 Financial Markets Preview: Hoping the pause is brief
...chg (A) Johnson Chemical Pharmaceutical Works Co. Ltd. (GreTai:4747) (B) 12/25/13 ~$6.0 NA $73.7 NA
Mycenax Biotech Inc.
...
Read More
BioCentury
|
Jan 6, 2014
Financial News
Mycenax completes IPO
...NT$843.4 million ($27.8 million) Shares: 13 million Price: NT$65 Shares after offering: 110.3 million Note:
Mycenax
...
Read More
Items per page:
10
1 - 3 of 3
BioCentury
|
Jul 25, 2016
Strategy
Paving the way
...Korea Intas Pharmaceuticals Ltd. Mkt in India Novartis AG (NYSE:NVS; SIX:NOVN) Registration in U.S., EU
Mycenax Biotech Inc.
...
Read More
BioCentury
|
Jan 6, 2014
Finance
2014 Financial Markets Preview: Hoping the pause is brief
...chg (A) Johnson Chemical Pharmaceutical Works Co. Ltd. (GreTai:4747) (B) 12/25/13 ~$6.0 NA $73.7 NA
Mycenax Biotech Inc.
...
Read More
BioCentury
|
Jan 6, 2014
Financial News
Mycenax completes IPO
...NT$843.4 million ($27.8 million) Shares: 13 million Price: NT$65 Shares after offering: 110.3 million Note:
Mycenax
...
Read More
Items per page:
10
1 - 3 of 3
Previous page
Next page